Actively Recruiting
Study on Bone and Joint Health in Male Patients with Severe Hemophilia A Using Recombinant Factor VIII Fc rFVIIIFc Treatment
Led by Tri-Service General Hospital · Updated on 2024-04-10
45
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients with severe hemophilia A to evaluate the effects of recombinant Factor VIII Fc rFVIIIFc on joint and bone health. The study aims to compare clinical outcomes from one year before and after switching to an extended half-life EHL treatment and to identify biomarkers that could make monitoring joint and bone health easier and more convenient. This study emphasizes the importance of rFVIIIFc in improving clinical outcomes related to joint and bone conditions in hemophilia A patients. The study involves systematic assessments of joint and bone health using tools like Haemophilia Early Arthropathy Detection HEAD-US, Hemophilia Joint Health Score HJHS, and DEXA scans. Blood tests will measure serum biomarkers including CTX-II, COMP, hsCRP, TNF-a, CTX-I, sRANKL, OPG, and Osteopontin OPN. Quality of life will also be evaluated using questionnaires such as Haem-A-QoL and EQ-5D. The study includes both prospective and retrospective components, allowing up to five years of follow-up. Participants will undergo regular joint and bone evaluations along with blood marker testing to monitor changes over time. The research team will collect data on joint and bone health before and after enrollment, focusing on systematic assessments and serum markers. These evaluations aim to provide a time-saving and accessible method for monitoring hemophilia-related joint and bone health. The total study duration for each participant may extend up to five years to capture long-term outcomes.
CONDITIONS
Brief Title
A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)
Research Team
Y
Yeu-Chin Chen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here